Skip to main content
Show full summary

Question HL15254: tabled on 26 April 2021 and due for answer by 11 May 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government when they expect to receive a report from the National Institute for Clinical Excellence on the (1) efficacy, and (2) cost effectiveness, of the daratumumab treatment for myeloma; how long that evaluation has been in progress; and when this treatment is likely to be fully funded for the treatment of patients in the NHS.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.